| US 7,460,911 B2 | ||
| System and method suitable for treatment of a patient with a neurological deficit by sequentially stimulating neural pathways using a system of discrete implantable medical devices | ||
| Gregoire Cosendai, Cudrefin (Switzerland); Ytizhak Zilberman, Santa Clarita, Calif. (US); Doug Kuschner, Santa Clarita, Calif. (US); Anne Marie Ripley, Los Angeles, Calif. (US); Ruth Turk, Farnham (United Kingdom); Jane Burridge, Salisbury (United Kingdom); Scott V. Notley, Southhampton (United Kingdom); Ross Davis, Melbourne Beach, Fla. (US); Morten Hansen, Valencia, Calif. (US); Lee Jay Mandell, West Hills, Calif. (US); Joseph H. Schulman, Santa Clarita, Calif. (US); Robert Dan Dell, Valancia, Calif. (US); and John C. Gord, Venice, Calif. (US) | ||
| Assigned to Alfred E. Mann Foundation for Scientific Research, Santa Clara, Calif. (US) | ||
| Filed on Dec. 03, 2004, as Appl. No. 11/4,758. | ||
| Application 10/391424 is a division of application No. 09/677384, filed on Sep. 30, 2000, granted, now 6,564,807. | ||
| Application 09/677384 is a division of application No. 09/048827, filed on Mar. 25, 1998, granted, now 6,164,284. | ||
| Application 11/004758 is a continuation in part of application No. 10/391424, filed on Mar. 17, 2003, abandoned. | ||
| Application 09/048827 is a continuation in part of application No. 09/030106, filed on Feb. 25, 1998, granted, now 6,185,452. | ||
| Claims priority of provisional application 60/039164, filed on Feb. 26, 1997. | ||
| Claims priority of provisional application 60/042447, filed on Mar. 27, 1997. | ||
| Prior Publication US 2005/0137648 A1, Jun. 23, 2005 | ||
| Int. Cl. A61N 1/08 (2006.01) | ||
| U.S. Cl. 607—48 [607/60; 128/899] | 43 Claims |
| 41. A system for determining the movement of a body portion associated with a selected muscle or muscle group, said system
comprising:
a first discrete implantable device suitable for implantation in a first portion of the selected muscle or muscle group;
a second discrete implantable device suitable for implantation in a second portion of the selected muscle or muscle group;
wherein each of said discrete implantable devices is contained within a sealed elongate housing having an axial dimension
of less than 60 mm and a lateral dimension of less than 6 mm, whereby said housings are suitable for injection into the patient's
body; and
wherein said discrete implantable devices are configured to wirelessly communicate signals to determine their relative distance
and accordingly the relative extension or retraction of the selected muscle or muscle group and accordingly movement of the
associated body portion.
|